🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The standard treatment for PTCL is CHOP (cyclophosphamide (C), adriamycin (...
Status
Completed
Location
Yale Comprehensive Cancer Center at Yale University School of Medicine
Start Date
2005-11
Trial ID
NCT00337987
RATIONALE: Denileukin diftitox may be able to make the body build an immune...
Status
Completed
Location
Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support
Start Date
2004-03
Trial ID
NCT00082914
Treatments Being Tested
This is an open-label, clinical efficacy study of Ipilimumab in patients wi...
Status
Terminated
Location
James Graham Brown Cancer Center
Start Date
2012-01
Trial ID
NCT02009384
Treatments Being Tested
Epithelial ovarian cancer (OC) is the most lethal gynecologic cancer: nearl...
Status
Active Not Recruiting
Location
UPMC Hillman Cancer Center
Start Date
2022-09-30
Trial ID
NCT05200559
Treatments Being Tested
Primary Objective: 1\. To assess the response rate of ONTAK in Systemic Ma...
Status
Completed
Location
The University of Texas M.D. Anderson Cancer Center
Start Date
2004-07
Trial ID
NCT00493129
Treatments Being Tested
This study is to assess the efficacy of Neihulizumab versus "conventional t...
Status
Withdrawn
Location
MD Anderson Cancer Center
Start Date
2016-07
Trial ID
NCT02694770
Treatments Being Tested
RATIONALE: Combinations of biological substances in denileukin diftitox may...
Status
Completed
Location
Robert H. Lurie Comprehensive Cancer Center at Northwestern University
Start Date
2005-04
Trial ID
NCT00278369
Treatments Being Tested
The primary goal of this study is to determine the feasibility and safety o...
Status
Terminated
Location
Barbara Ann Karmanos Cancer Institute
Start Date
2010-11
Trial ID
NCT01251952
Treatments Being Tested
RATIONALE: Biological therapies, such as denileukin difitox, may stimulate ...
Status
Completed
Location
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Start Date
2005-04
Trial ID
NCT00357448
RATIONALE: Denileukin diftitox may be able to deliver cancer-killing substa...
Status
Completed
Location
Veterans Affairs Medical Center - Miami
Start Date
1999-11
Trial ID
NCT00006345
Treatments Being Tested